Results

Total Results: 1,987 records

Showing results for "harms".

41. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - prostatectomy (RP) may reduce mortality and metastases more than watchful waiting (WW) but causes more harms … Harms were lowest with AM compared with RP or EBR plus AD or AS versus photodynamic therapy. … Associated harms were unclear. … Harms are greater with RP. AM was compared with RP or EBR plus AD in PSA screen–detected CLPC. … However, it may also result in an increase in harms.

42. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - Key Question Strength of Evidence Conclusion GI and CV harms: Celecoxib High for GI harms vs. nonselective … GI and CV harms: Partially selective NSAIDs GI harms: Moderate for meloxicam and etodolac (fewer trials … GI and CV harms: Nonselective NSAIDs GI harms: High for naproxen, ibuprofen, and diclofenac (consistent … Key Question Strength of Evidence Conclusion GI and CV harms: Nonselective NSAIDs (continued) CV harms … GI and CV harms: Aspirin Moderate for GI and CV harms (many trials, but almost exclusively in patients

43. Should subclinical hypothroidism be treated? | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/should-subclinical-hypothroidism-be-treated
    March 21, 2008 - how well the test, treatment, or intervention works   There is significant potential for side effects/harms … Harms: Are there risks, side effects, or harms you are concerned about? … specify what those are: There are potential harms … from treatment and potential harms from non treatment. 9. … What are the benefits and harms of treating patients with subclinical hypothroidism vs watchfull waiting

44. Pressure-Ulcer-Treatment Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
    May 01, 2013 - They were included for the assessment of harms if they reported on harms of treatments for which data … (continued) Harms: Local Wound Applications Dressings and topical therapies Moderate Harms reported … harms by ulcer characteristics. … harms by patient characteristics. … harms by patient care setting.

45. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
    January 01, 2010 - What are the benefits and harms of rhythm control compared to rate control (including newer agents)? … What are the benefits and harms of strict versus more lenient rate control? 2. … What are the benefits and harms of different anticoagulation and antiplatelet agents and monitoring … What are the benefits and harms of antiarrhythmic agents for acute conversion of AF to sinus rhythm … What are the benefits and harms of ACEIs, ARBs and statins in the prevention of new AF and progression

46. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
    May 01, 2017 - High SOE for clinically significant harms associated with risperidone Harms including weight gain … High SOE for clinically significant harms associated with aripiprazole Harms including weight gain … Low SOE for minimal harms No clinically significant harms reported in any study N-acetylcysteine … Low SOE for minimal harms No study reported harms considered clinically important Table B. … Harms reporting varied across studies; some studies amply described how harms were tracked, while others

47. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
    January 01, 2008 - effects of treating older patients with antipsychotics and requests information on the benefits and harms … ), do the typical and atypical antipsychotic drugs differ in benefits (efficacy, effectiveness) or harms … schizophrenia, do the atypical antipsychotic drugs differ in benefits (efficacy, effectiveness) or harms … , do the typical and atypical antipsychotic drugs differ in benefits (efficacy, effectiveness) or harms … review from the EHC Program focus on key long-term, real life effectiveness trials and comparative harms

48. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - Osteoporosis treatment harms vary by drug class. … >100 subjects for rare harms and >1000 subjects for other harms KQ 5: Effect of drug treatment … Timing Setting Study Design KQ 7: Harms of drug treatment holidays KQ8: Predictors of harms … >100 subjects for rare harms and >1000 for other harms Abbreviations: ALP = alkaline phosphatase … ) • Harms (Serious adverse events and specific harms as listed in Table 2) Outcome predictors (

49. Part 3: Key Question - Trauma Informed Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-care-key-questions.pdf
    January 01, 2022 - the state of the science related to the effectiveness of TIC on health and healthcare outcomes and harms … What is the evidence of benefits and/or harms of TIC on outcomes for patients/clients? 1a. … What is the evidence of benefits and/or harms of TIC on outcomes for patients/clients? 2a. … of TIC (KQ1) Youth (children and adolescents), effectiveness and harms of TIC (KQ2) Population … of TIC (KQ1) Youth (children and adolescents), effectiveness and harms of TIC (KQ2) Intervention

50. Urethral Disorders | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/urethral-disorders
    September 15, 2014 - Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments Systematic Review

51. What is the most effective therapy for a depressed patient who has not responded to an SSRI? | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-most-effective-therapy-for-a-depressed-patient-who-has-not-responded-to-an-ssri
    March 17, 2008 - how well the test, treatment, or intervention works   There is significant potential for side effects/harms … Screening or diagnosis/identification for a particular disease, or risk assessment for a disease   Risks or harms … Harms: Are there risks, side effects, or harms you are concerned about? … specify what those are: There are potential harms … to the different treatment options and there are potential harms of inadequate treatmeent. 9.

52. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
    January 01, 2005 - Explicit approach to translation of evidence (but not rating of strength) Explicit description of harms … (not available for review) Approach to translating evidence not described Included description of harms … How does product discuss strength of evidence about benefits and/or harms? … NZGG: HRT—New Information for Women Appropriate Audience Compare Alternatives Benefits and Harms … Pain Guidelines Group: Acute Low Back Pain Appropriate Audience Compare Alternatives Benefits and Harms

53. Urine and Urination | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/urine-and-urination
    September 15, 2014 - Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments Systematic Review

54. Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/multiple-sclerosis/research
    April 28, 2015 - disease-modifying treatment (DMT) for multiple sclerosis (MS) by examining the long-term benefits and harms … information: 16 of these contained complete information to allow full analysis of long-term benefits and harms … Limited low-strength evidence suggests that long-term harms do not differ from short-term harms.

55. Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-234-headaches-pregnancy-summary.pdf
    November 01, 2020 -  A single primary study provided insufficient (direct) evidence to make conclusions about the harms … The uncertainty about the comparative effectiveness and harms of various treatment options underscores … ; fetal/child harms were not reported. …  No indirect evidence regarding harms of nonpharmacologic interventions in pregnancy was identified … For additional information on harms, we also searched for relevant SRs of interventions in women in

56. Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
    November 01, 2020 -  A single primary study provided insufficient (direct) evidence to make conclusions about the harms … The uncertainty about the comparative effectiveness and harms of various treatment options underscores … ; fetal/child harms were not reported. …  No indirect evidence regarding harms of nonpharmacologic interventions in pregnancy was identified … For additional information on harms, we also searched for relevant SRs of interventions in women in

57. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
    January 01, 2010 - Anonymous individual Nomination Summary: The nominator questions the comparative effectiveness and harms … to another insomnia intervention Outcome(s): Quality of life, sleep quality, fatigue, and harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms, including … Insomnia can be associated with various harms, including decreased quality of life, cognitive deficits … A review on this topic will help to compare the relative benefits and harms of these interventions.

58. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time … Harms of lidocaine patch versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk

59. Efficacy and Safety of Screening for Postpartum Depression | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research
    April 09, 2013 - Structured Abstract Objectives To describe the benefits and harms of specific tools and strategies … evaluated the performance of screening instruments for postpartum depression, potential benefits and harms … estimate the effects of screening for postpartum depression on the overall balance of benefits and harms … Because the balance of benefits and harms, at both the individual level and health system level, is highly

60. Otitis Media With Effusion: Comparative Effectiveness of Treatments | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/ear-infection/research
    May 04, 2013 - Structured Abstract Objectives To compare benefits and harms of strategies currently in use for managing … We compared benefits and harms among these treatments: tympanostomy tubes (TT), myringotomy (myr), adenoidectomy … Findings are reported for clinical and functional outcomes, and harms. … adenoid reduce OME and improve hearing in the short term, but both treatments also have associated harms